Myeloproliferative Neoplasm, BCR-ABL1 Negative

Myeloproliferative Neoplasm, BCR-ABL1 Negative — Trials · CancerIndex

Clinical trials

Registered studies

333 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 50
Ph III recruiting: 7
Growth YoY: —
Industry share: 41%
Top sponsor: City of Hope Medical Center
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05875805	A Telehealth Advance Care Planning Intervention(SICP RCT)	recruiting	N/A	207	University of RochesterOTHER	1	Sep 11, 2026	clinicaltrials
NCT06361641	Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes(PHEMOP)	recruiting	N/A	70	University Hospital, AngersOTHER_GOV	1	Aug 10, 2026	clinicaltrials